112 related articles for article (PubMed ID: 3753025)
1. [A phase II study of mitoxantrone in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
Masaoka T; Oguma S; Shibata H; Nagai K; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2793-9. PubMed ID: 3753025
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of mitoxantrone in patients with acute leukemia].
Kimura K; Yoshikawa S; Yoshikawa H; Yamada K; Hirano M; Ikeda Y; Ohta K; Ohara K; Kobayashi M; Shirakawa S
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2573-80. PubMed ID: 3740858
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of mitoxantrone for acute leukemia].
Oguma S; Tatsumi Y; Hirayama F; Tani Y; Kubota Y; Kanakura Y; Ueda T; Nakamura H; Shibata H; Masaoka T
Gan To Kagaku Ryoho; 1984 Mar; 11(3):497-501. PubMed ID: 6703723
[TBL] [Abstract][Full Text] [Related]
4. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study of mitoxantrone for hematologic malignancies].
Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
[TBL] [Abstract][Full Text] [Related]
7. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II trial of mitoxantrone in acute leukemia.
Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
[TBL] [Abstract][Full Text] [Related]
9. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
[TBL] [Abstract][Full Text] [Related]
10. [A phase II study of mitoxantrone in malignant lymphoma].
Ibuka T; Sasaki T; Imai K; Sakai Y
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2612-7. PubMed ID: 3740861
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone in patients with acute leukemia in relapse.
Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of mitoxantrone in refractory acute leukemia.
Estey EH; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
Cancer Treat Rep; 1983 Apr; 67(4):389-90. PubMed ID: 6850655
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of mitoxantrone in advanced breast cancer].
Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Moore JO; Olsen GA
Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
[TBL] [Abstract][Full Text] [Related]
15. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM
Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703
[TBL] [Abstract][Full Text] [Related]
17. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
18. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
19. The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study.
Wrzesien-Kus A; Robak T; Jamroziak K; Wierzbowska A; Dmoszynska A; Adamczyk-Cioch M; Kuliczkowski K; Mazur G; Holowiecki J; Konopka L; Maj S; Marianska B; Zawilska K;
Neoplasma; 2002; 49(6):405-11. PubMed ID: 12584589
[TBL] [Abstract][Full Text] [Related]
20. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
Kimura K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
